WASHINGTON, Nov. 12 /PRNewswire-USNewswire/ -- Women's Health Weekly recently
reported that America's pharmaceutical research and biotechnology companies
are working on nearly 1,000 life-changing medicines for diseases affecting
women, according to a new report released by the Pharmaceutical Research and
Manufacturers of America (PhRMA). The medicines are awaiting approval by the
U.S. Food and Drug Administration or are in human clinical trials.
In the U.S., diseases that disproportionately affect women include diabetes,
which has reached epidemic proportions and affects 11 million women
nationwide. Autoimmune diseases strike women three times more and anxiety and
depression two times more women than men. The number one killer of American
women is heart disease.
The report lists 969 new medicines in development. They include 112 new
treatments for breast cancer, 86 new treatments for obstetric/gynecologic
conditions, 76 for asthma, 114 for autoimmune diseases, 155 for diabetes, 131
for arthritis, and 80 for Alzheimer's disease.
"America's pharmaceutical research and biotechnology companies continue making
exciting progress in the search for new cures and treatments for diseases of
special concern to women," said PhRMA Senior Vice President Ken Johnson in his
remarks at the press briefing at the Cold Spring Harbor Laboratory on Long
Island, New York. "We live in an era of medical discovery in which we
understand more and more about the unique biological and behavioral
differences between men and women and their respective health care needs. This
knowledge is inspiring a continuing medical revolution that is bringing new
hope to women around the world in the form of promising new treatments and
cures."
New York Biotechnology Association Executive Director Nathan Tinker noted that
incredible progress is being made by America's biotechnology and
pharmaceutical research companies in developing new and more effective
treatments for the wide range of diseases that affect women. "Cooperation
between the country's educational facilities, research hospitals,
laboratories, and innovative biopharmaceutical companies has proven critical
to this success," said Tinker.
Read the original article in Women's Health Weekly.
SOURCE Pharmaceutical Research and Manufacturers of America
